Your session is about to expire
← Back to Search
Acupuncture for Myasthenia Gravis
N/A
Waitlist Available
Led By Gaurav K Guliani, MD
Research Sponsored by HealthPartners Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre/post - 12 weeks
Awards & highlights
Study Summary
This trial will test whether acupuncture can help improve quality of life for people with myasthenia gravis.
Who is the study for?
This trial is for adults aged 18-80 with Myasthenia Gravis. Participants must be able to consent and speak English. Excluded are those with bleeding disorders, heart arrhythmias, stimulator devices, recent other trials participation, pregnancy or planning to become pregnant during the study, substance abuse issues, outside acupuncture treatment while enrolled, or serious neurological conditions.Check my eligibility
What is being tested?
The AcuMG trial tests if acupuncture can improve life quality in people with Myasthenia Gravis. It involves 20 participants receiving treatments twice weekly for 12 weeks. They're split into two groups: one starts immediately and the other after a delay of 12 weeks (serving as a control group initially).See study design
What are the potential side effects?
Potential side effects from acupuncture may include minor bleeding or bruising at needle sites, rare instances of fainting or dizziness during treatment sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre/post - 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre/post - 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To determine the effect of acupuncture on quality of life in patients with MG
Secondary outcome measures
To determine the effect of acupuncture on activities of daily living in patients with MG
Side effects data
From 2013 Phase 1 & 2 trial • 104 Patients • NCT013058112%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate StartExperimental Treatment1 Intervention
Patients will receive acupuncture treatment two times per week for 12 weeks.
Group II: Delayed startActive Control1 Intervention
Patients will act as control group for the first 12 weeks then will receive acupuncture treatment two times per week for 12 weeks.
Find a Location
Who is running the clinical trial?
HealthPartners InstituteLead Sponsor
184 Previous Clinical Trials
3,716,139 Total Patients Enrolled
Gaurav K Guliani, MDPrincipal InvestigatorHealthPartners Neurology
Amanda A Herrmann, PhDPrincipal InvestigatorHealthPartners Neuroscience Research
2 Previous Clinical Trials
63 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not pregnant, breastfeeding, nor planning to become pregnant during the study.I do not speak English.I have been diagnosed with myasthenia gravis.I am between 18 and 80 years old.I am willing to participate in all study related activities.I have a current or recent issue with substance use.I have a history of bleeding disorders or fainting when needles are used.I am not participating in any acupuncture treatments outside of this study.I have a history of serious neurological, psychiatric, or chronic pain disorders, or seizures.
Research Study Groups:
This trial has the following groups:- Group 1: Delayed start
- Group 2: Immediate Start
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many research participants have enrolled in this investigation?
"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial, initially published on May 25th 2022, is actively recruiting participants. Approximately 20 individuals are needed from a single research site."
Answered by AI
Are new participants welcomed to join this experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial is still recruiting as of July 27th 2022; the study was first advertised on May 25th 2022 and requires 20 patients from a single site."
Answered by AI
Am I eligible to participate in this research effort?
"This trial is seeking 20 individuals diagnosed with myasthenia gravis aged between 18 and 80. The primary requirements are the ability to provide informed consent, age range of 18-80 years old, and a confirmed diagnosis of MG."
Answered by AI
Is the age range for recruitment of participants in this trial restricted to individuals over 25 years old?
"The parameters for enrollment in this medical study are those aged 18 to 80. Additionally, there 13 trials available to minors and 69 trails applicable to seniors over 65 years old."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger